Doribax
Recall
|
Medicines
|
14/03/2014
"Janssen-Cilag Pharma GmbH" informed its supplied customers in a letter dated March 13, 2014, that due to continuous assessment of the product portfolio and return of the license to Shionogi & Co, Ltd, the Group has decided to recall "Doribax 500 mg Powder for the Preparation of an Infusion Solution" from all markets worldwide.
| Name of the medicinal product | Doribax 500 mg Pulver zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | EU/1/08/467/001 |
| Marketing authorisation holder | Janssen-Cilag International NV, Belgien Vertrieb und Durchführung Rückruf: Janssen-Cilag Pharma GmbH |
| Batch number(s) | Alle Chargen |
| Classification of the recall | 3 |
| BASG reference number | INS - 640.001 - 1014 |
Further inquiry note
Page last modified:
12/07/2022